_×
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > TREM-2 (TREM2)

TREM-2 (TREM2)

TREM-2 may have a role in chronic inflammations and may stimulate production of constitutive rather than inflammatory chemokines and cytokines. TREM-2 forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells.

Sino Biological Inc.
Contents

TREM-2 (TREM2) Related Products

TREM-2 (TREM2) Proteins

TREM-2 (TREM2) Antibodies

TREM-2 (TREM2) ELISA Pair sets

  •  

TREM-2 (TREM2) cDNA Clones

TREM-2 (TREM2) Related Areas

Immunology>>Innate Immunity>>Monocyte/Macrophage>>Macrophage Marker / Monocyte Marker>>TREM-2/TREM2

TREM-2 (TREM2) Related Pathways

TREM-2 (TREM2) Alternative Names

TREM-2, Trem2a, Trem2b, Trem2c

Summaries for TREM-2 (TREM2)

Entrez Gene summary for TREM-2 (TREM2):

The protein encoded by TREM2 gene is a membrane protein that forms a receptor signaling complex with TYROBP. The encoded protein may be involved in chronic inflammation by triggering the production of constitutive inflammatory cytokines. Defects in TREM2 gene are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). [provided by RefSeq, Jul 2008]

OMIM - description for TREM-2 (TREM2):

Monocyte/macrophage- and neutrophil-mediated inflammatory responses can be stimulated through a variety of receptors, including G protein-linked 7-transmembrane receptors (e.g., FPR1; ), Fc receptors , CD14 and Toll-like receptors (e.g., TLR4; ), and cytokine receptors (e.g., IFNGR1; ). Engagement of these receptors can also prime myeloid cells to respond to other stimuli. Myeloid cells express receptors belonging to the Ig superfamily, such as TREM2, or to the C-type lectin superfamily. Depending on their transmembrane and cytoplasmic sequence structure, these receptors have either activating (e.g., KIR2DS1; ) or inhibitory functions (e.g., KIR2DL1; ).

Wikipedia summary for TREM-2 (TREM2):

Triggering receptor expressed on myeloid cells 2 is a protein that in humans is encoded by the TREM2 gene.
Monocyte/macrophage- and neutrophil-mediated inflammatory responses can be stimulated through a variety of receptors, including G protein-linked 7-transmembrane receptors (e.g., FPR1; ), Fc receptors , CD14 and Toll-like receptors (e.g., TLR4; ), and cytokine receptors (e.g., IFNGR1; ). Engagement of these receptors can also prime myeloid cells to respond to other stimuli. Myeloid cells express receptors belonging to the Ig superfamily, such as TREM2, or to the C-type lectin superfamily. Depending on their transmembrane and cytoplasmic sequence structure, these receptors have either activating (e.g., KIR2DS1; ) or inhibitory functions (e.g., KIR2DL1; ).[supplied by OMIM]

Human TREM-2 (TREM2) Protein General Information

 

Protein names

Triggering receptor expressed on myeloid cells 2
Short name=TREM-2

Sequence length

230 AA.

Domain

Immunoglobulin domain
Signal
Transmembrane
Transmembrane helix

Sequence similarities:

Contains 1 Ig-like V-type (immunoglobulin-like) domain.

Sequence caution:

The sequence BAB78736.1 differs from that shown. Reason: Erroneous initiation.

Subunit structure

Interacts with TYROBP/DAP12 .

Subcellular location: Isoform 1: Cell membrane; Single-pass type I membrane protein .
Isoform 2: Secreted .
Isoform 3: Secreted .
Tissue specificity

Expressed on macrophages and dendritic cells but not on granulocytes or monocytes. In the CNS strongest expression seen in the basal ganglia, corpus callosum, medulla oblongata and spinal cord.

Involvement in disease: Defects in TREM2 are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) ; also known as presenile dementia with bone cysts or Nasu-Hakola disease (NHD). PLOSL is a recessively inherited disease characterized by a combination of psychotic symptoms rapidly progressing to presenile dementia and bone cysts restricted to wrists and ankles. PLOSL has a global distribution, although most of the patients have been diagnosed in Finland and Japan, with an estimated population prevalence of 2x10(-6) in the Finns.

General information above from UniProt

Function for TREM-2 (TREM2) Protein

UniProtKB:

TREM-2 may have a role in chronic inflammations and may stimulate production of constitutive rather than inflammatory chemokines and cytokines. TREM-2 forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells.

Genatlas:

  • TREM-2 plays a role in chronic inflammatory response
  • TREM-2 plays a critical role in the differentiation of mononuclear myeloid precursors into functional multinucleated osteoclasts
  • TREM-2 regulates osteoclast multinucleation as well as resorption and migration of mature osteoclast
  • TREM-2 delivers intracellular signals through the adaptor TYROBP to regulate myeloid cell function both within and outside the immune system
  • TREM-2 is expressed on newly differentiated and alternatively activated macrophages and functions to restrain macrophage activation
  • TYROBP and TREM2, with SYK are required for the cytokine-induced formation of giant cells
  • TREM-2's signaling is an important pathway to promote healing of wounds in the colon where stem cell replacement is necessary

Homology for human TREM-2 (TREM2)

  • ortholog to murine Trem2c-pending
  • homolog to drosophila CG2304
  • homolog to C.elegans Y119C1B.5

Phenotype Information for TREM-2 (TREM2)

Gene/Locus Phenotype
TREM2 Nasu-Hakola disease

Phenotype Information for TREM-2 (TREM2) from OMIM (Online Mendelian Inheritance in Man)

Drugs for TREM-2 (TREM2)

Hot Molecules